All News

“Having new options is important, particularly when patients have already been through chemotherapy and some of the other therapies that are available,” said Dr. John P. Leonard.

From cancer to COVID-19, our patient stories can help others take sickness and disease seriously.

From a new trial in Canada looking at therapeutics to help prevent severe symptoms of COVID-19 in patients with cancer to updated guidelines from the American Cancer Society on taking the HPV vaccine to prevent certain cancers, here’s what’s making the headlines in the cancer space this week.

Data from a phase 2 study presented during the 2020 ASCO Virtual Scientific Program demonstrated that Avastin (bevacizumab) in combination with Tarceva (erlotinib) was well tolerated and produced encouraging clinical outcomes in patients with advanced hereditary leiomyomatosis and renal cell carcinoma or sporadic papillary renal cell carcinoma.

Data from a phase 3 study presented at the 2020 ASCO Virtual Scientific Program showed that treatment with savolitinib demonstrated encouraging efficacy and an improved safety over standard-of-care Sutent (sunitinib) in patients with MET-driven papillary renal cell carcinoma.

Researchers indicate that the current data suggest that race does not have a negative prognostic effect in patients with castration-resistant prostate cancer with bone metastases.

With the passing of CURE co-founder Kathy LaTour, one contributor remembers the advice, friendship and kindness that Kathy passed on to her that helped her to share her own cancer story.

Tired of throwing out overripe, brown bananas? This simple and delicious recipe for banana oatmeal muffins from the oncology dietitians at the John Theurer Cancer Center will put them to good use.

“We're not going to turn our back on our cancer patients, we're not going to make it a choice between COVID and cancer, but rather we're going to make it and we have to treat both,” said Dr. Pat Basu, President and CEO of Cancer Treatment Centers of America.

The risk for a major cardiovascular event was reduced by more than half in patients who received Relumina compared to the hormone associated therapy leuprolide.

A roundup of the latest news and updates for patients with Renal Cell Carcinoma from CURE®.

One cancer survivor looks at all the ways they might have gotten cancer, and wonders if any of those risk factors will factor into recurrence.

The Food and Drug Administration approved the oral combination of Inquovi (Dacogen [decitabine] and cedazuridine) for certain adult patients with myelodysplastic syndromes (MDS).

“We learned from previous prospective studies (that) using chemoimmunotherapy for those patients with TP53 aberrations, the survival data compared with others that do not harbor this mutation are much less favorable,” said Dr. Jia Ruan.

Most of us never stop to think about how much information one little sample of blood can give us and our physicians.

“It is important to note that the data predates the widespread use of BTK inhibitors and even cellular therapies such as CAR T-cell therapy, specifically,” Dr. Reem Karmali said in an interview. “And so, it doesn't reliably reflect the potential advancements and survival that we've been able to achieve with these novel targeted therapies.”

“As people go through the process, it’s important that you don't minimize community health workers that are not certified because at the end of the day that paper doesn't create the bond,” says Rosalia Guerrero-Luera.

Immunotherapy is a wonderful testament to the benefits that arise from our growing understanding of the incredibly intricate human immune system.

No longer were cancer fighters on another planet. We were right there with you, commiserating through the hardships and sharing the latest entertainment finds to help pass the time.

In the 2020 special issue of CURE on Immunotherapy, we take a look at how the field of immunotherapy continues to grow despite challenges from the COVID-19 pandemic.

Cutting-edge medical information and first-person accounts empower patients to evaluate immunotherapy as a treatment option, one organization attests.

A fellow cancer survivor mourns the passing of Kathy LaTour.

Celebrating is a vital part of survivorship and those affected by cancer should be allowed to voice their opinions openly.

From a care team giving a patient with metastatic breast cancer a taste of Paris after a planned trip had to be canceled to a local group of veterans honoring one of their own after a lung cancer diagnosis, here’s what’s making the headlines in the cancer space this week.

“I think that when people are diagnosed with cancer, cancer really becomes their life,” Alessandra Tantawi said in a recent interview with CURE®. “And it's so hard to just have a ‘normal day’ where you can focus on anything besides cancer. And I think what's important is to spend time that is outside of the cancer treatment.”

For survivor Michele Grimes, time at home during the pandemic fosters an opportunity for reflection and growth.

Incessant and challenging these diseases demand our equal attention in our lives.

This week’s “Cooking with CURE” recipe makes it easy to include more vegetables into your diet, with a delicious egg hash that is sure to be a hit.